REBEKKA EVANS: Open Payments
NPI 1740041508 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 60 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $873 · 2025 $1,386
Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $278 |
| Galderma Laboratories, L.P. | 7 | $205 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| Almirall LLC | 5 | $114 |
| Organon LLC | 4 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| Amgen Inc. | 4 | $85 |
| Lilly USA, LLC | 3 | $73 |
| GENZYME CORPORATION | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $57 |
Products named: SKYRIZI, DUPIXENT, NEMLUVIO, Klisyri, OTEZLA, TREMFYA, AKLIEF, SOFDRA.
Industry payments across FL — which companies pay providers there.
